| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41,367 |
38,162 |
$11.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40,082 |
35,040 |
$10.83M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,678 |
19,737 |
$1.12M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,486 |
5,666 |
$84K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
497 |
479 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,772 |
1,656 |
$57K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
699 |
208 |
$46K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
161 |
127 |
$41K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,449 |
5,484 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
20,998 |
18,124 |
$31K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
843 |
798 |
$31K |
| G0378 |
Hospital observation service, per hour |
84 |
49 |
$25K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,320 |
1,188 |
$18K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
112 |
37 |
$9K |
| 80053 |
Comprehensive metabolic panel |
31,545 |
27,419 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
426 |
368 |
$5K |
| 85027 |
|
37,005 |
32,053 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,407 |
9,336 |
$4K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
21 |
20 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,231 |
7,751 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
10,220 |
9,050 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
24 |
12 |
$2K |
| 84484 |
|
4,414 |
3,390 |
$1K |
| 85610 |
|
4,214 |
3,559 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,099 |
2,727 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,925 |
2,780 |
$981.89 |
| 81001 |
|
19,962 |
17,758 |
$778.01 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
40 |
36 |
$751.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,521 |
2,206 |
$454.96 |
| 71046 |
Radiologic examination, chest; 2 views |
1,041 |
944 |
$383.98 |
| 87081 |
|
1,255 |
1,197 |
$328.07 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,553 |
6,058 |
$250.74 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
552 |
491 |
$158.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,078 |
5,731 |
$137.74 |
| 87070 |
|
938 |
881 |
$126.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,013 |
859 |
$106.06 |
| 87807 |
|
1,185 |
1,150 |
$89.47 |
| 83690 |
|
5,676 |
4,992 |
$65.57 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,994 |
4,594 |
$54.44 |
| 84703 |
|
2,031 |
1,872 |
$44.68 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,802 |
1,692 |
$38.62 |
| 81025 |
|
4,406 |
4,096 |
$34.47 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
12 |
$25.30 |
| 87040 |
|
217 |
176 |
$22.94 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,185 |
1,096 |
$19.24 |
| 84443 |
Thyroid stimulating hormone (TSH) |
641 |
550 |
$15.12 |
| 83735 |
|
3,796 |
3,250 |
$14.88 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
180 |
164 |
$12.79 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,007 |
902 |
$10.80 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
620 |
500 |
$9.67 |
| 85730 |
|
2,075 |
1,765 |
$7.50 |
| 82150 |
|
543 |
475 |
$5.83 |
| 82248 |
|
766 |
679 |
$4.84 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
138 |
127 |
$2.87 |
| 81003 |
|
541 |
475 |
$2.70 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
29 |
28 |
$0.00 |
| 83880 |
|
789 |
664 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
55 |
54 |
$0.00 |
| 83605 |
|
482 |
416 |
$0.00 |
| 85652 |
|
61 |
58 |
$0.00 |
| 82550 |
|
77 |
68 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
90 |
86 |
$0.00 |
| 74019 |
|
15 |
14 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
25 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
39 |
38 |
$0.00 |
| 82553 |
|
31 |
26 |
$0.00 |
| 83874 |
|
31 |
26 |
$0.00 |
| 87581 |
|
20 |
20 |
$0.00 |
| 87486 |
|
20 |
20 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
427 |
373 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
29 |
29 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
28 |
27 |
$0.00 |
| 87186 |
|
15 |
14 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
20 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20 |
20 |
$0.00 |